WO1997020845A1 - Pyrroloazepine derivatives - Google Patents

Pyrroloazepine derivatives Download PDF

Info

Publication number: WO1997020845A1
Authority: WO; WIPO (PCT)
Prior art keywords: alkyl; group represented; bond; represented; alkenylene
Prior art date: 1995-12-01

Application number

PCT/JP1996/003522

Other languages

English (en)

French (fr)

Inventor

Akira Mizuno

Makoto Shibata

Tomoe Iwamori

Tetsuo Shimamoto

Kyoko Nakanishi

Norio Inomata

Original Assignee

Suntory Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-01

Filing date

1996-12-02

Publication date

1997-06-12

1996-12-02 Application filed by Suntory Limited filed Critical Suntory Limited

1996-12-02 Priority to KR1019970705185A priority Critical patent/KR19980701788A/ko

1996-12-02 Priority to DE69620745T priority patent/DE69620745T2/de

1996-12-02 Priority to AT96939340T priority patent/ATE216388T1/de

1996-12-02 Priority to AU76558/96A priority patent/AU719230B2/en

1996-12-02 Priority to JP52115297A priority patent/JP3563076B2/ja

1996-12-02 Priority to IL12143296A priority patent/IL121432A/xx

1996-12-02 Priority to US08/875,495 priority patent/US5962448A/en

1996-12-02 Priority to EP96939340A priority patent/EP0807632B1/en

1997-06-12 Publication of WO1997020845A1 publication Critical patent/WO1997020845A1/ja

2001-03-09 Priority to US09/801,816 priority patent/US6489473B2/en

Links

CTVOZUFKICZROL-UHFFFAOYSA-N pyrrolo[3,2-b]azepine Chemical class C1=CC=CC2=NC=CC2=N1 CTVOZUFKICZROL-UHFFFAOYSA-N 0.000 title abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 6
125000004450 alkenylene group Chemical group 0.000 abstract 2
125000002947 alkylene group Chemical group 0.000 abstract 2
125000003710 aryl alkyl group Chemical group 0.000 abstract 2
DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 abstract 1
125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 abstract 1
125000004419 alkynylene group Chemical group 0.000 abstract 1
230000008485 antagonism Effects 0.000 abstract 1
208000026106 cerebrovascular disease Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
125000001072 heteroaryl group Chemical group 0.000 abstract 1
208000031225 myocardial ischemia Diseases 0.000 abstract 1
230000002093 peripheral effect Effects 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1
125000000168 pyrrolyl group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 abstract 1
125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1
230000001988 toxicity Effects 0.000 abstract 1
231100000419 toxicity Toxicity 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PCT/JP1996/003522 1995-12-01 1996-12-02 Pyrroloazepine derivatives WO1997020845A1 (en)

Priority Applications (9)

Application Number	Priority Date	Filing Date	Title
KR1019970705185A KR19980701788A (ko)	1995-12-01	1996-12-02	피롤로아제핀 유도체
DE69620745T DE69620745T2 (de)	1995-12-01	1996-12-02	Pyrroloazepin-derivate
AT96939340T ATE216388T1 (de)	1995-12-01	1996-12-02	Pyrroloazepin-derivate
AU76558/96A AU719230B2 (en)	1995-12-01	1996-12-02	Pyrroloazepine derivatives
JP52115297A JP3563076B2 (ja)	1995-12-01	1996-12-02	ピロロアゼピン誘導体
IL12143296A IL121432A (en)	1995-12-01	1996-12-02	Pyrrolo [3,2-C]azepine-4-one derivatives and pyrrolo [3,4-C]azepine-4-one derivatives their preparation and pharmaceutical compositions containing them
US08/875,495 US5962448A (en)	1995-12-01	1996-12-02	Pyrroloazepine derivatives
EP96939340A EP0807632B1 (en)	1995-12-01	1996-12-02	Pyrroloazepine derivatives
US09/801,816 US6489473B2 (en)	1995-12-01	2001-03-09	Pyrroloazepine derivatives

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
JP33571495		1995-12-01
JP7/335714		1995-12-01
JP8/46928		1996-02-09
JP4692896		1996-02-09

Related Child Applications (4)

Application Number	Title	Priority Date	Filing Date
US08/875,495 A-371-Of-International US5962448A (en)	1995-12-01	1996-12-02	Pyrroloazepine derivatives
US09/312,713 Continuation-In-Part US6258805B1 (en)	1995-12-01	1999-05-17	Pyrroloazepine derivatives
US09/312,713 Continuation US6258805B1 (en)	1995-12-01	1999-05-17	Pyrroloazepine derivatives
US09/801,816 Continuation US6489473B2 (en)	1995-12-01	2001-03-09	Pyrroloazepine derivatives

Publications (1)

Publication Number	Publication Date
WO1997020845A1 true WO1997020845A1 (en)	1997-06-12

Family

ID=26387089

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PCT/JP1996/003522 WO1997020845A1 (en)	1995-12-01	1996-12-02	Pyrroloazepine derivatives

Country Status (12)

Country	Link
US (4)	US5962448A (ja)
EP (1)	EP0807632B1 (ja)
JP (1)	JP3563076B2 (ja)
KR (1)	KR19980701788A (ja)
AT (1)	ATE216388T1 (ja)
AU (1)	AU719230B2 (ja)
CA (1)	CA2212092A1 (ja)
DE (1)	DE69620745T2 (ja)
ES (1)	ES2179218T3 (ja)
HU (1)	HUP9900672A3 (ja)
IL (1)	IL121432A (ja)
WO (1)	WO1997020845A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000048602A1 (en) *	1999-02-17	2000-08-24	Suntory Limited	Intermittent claudication therapeutic drugs comprising pyrroloazepines

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0807632B1 (en)	1995-12-01	2002-04-17	Suntory Limited	Pyrroloazepine derivatives
JPH10251258A (ja) *	1997-03-14	1998-09-22	Suntory Ltd	ピロロアゼピン系化合物
JPH11193289A (ja) *	1997-12-26	1999-07-21	Suntory Ltd	ピロールスルホンアミド誘導体
JPH11193290A (ja) *	1997-12-26	1999-07-21	Suntory Ltd	ピロールスルホンアミド系化合物
DE60008699T2 (de) *	1999-12-16	2005-01-13	Daiichi Suntory Pharma Co., Ltd.	Verfahren zur herstellung von optisch aktiven pyrroloazepinderivaten
FR3008975A1 (fr)	2013-07-23	2015-01-30	Servier Lab	Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2018236745A1 (en)	2017-06-20	2018-12-27	Carnot, Llc	COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF CARDIAC METABOLISM
EP3828182A4 (en) *	2018-07-23	2022-04-20	Sumitomo Dainippon Pharma Co., Ltd.	LACTAM DERIVATIVES WITH CONDENSED RING
US11780811B2 (en)	2020-06-30	2023-10-10	Imbria Pharmaceuticals, Inc.	Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11530184B2 (en)	2020-06-30	2022-12-20	Imbria Pharmaceuticals, Inc.	Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11883396B2 (en)	2021-05-03	2024-01-30	Imbria Pharmaceuticals, Inc.	Methods of treating kidney conditions using modified forms of trimetazidine
CN113788777B (zh) *	2021-09-07	2023-04-11	华中科技大学	一种制备1-取代-3-羰基吡咯的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH01151578A (ja) *	1987-09-03	1989-06-14	Glaxo Group Ltd	ラクタム誘導体
JPH02160786A (ja) *	1988-08-02	1990-06-20	Glaxo Group Ltd	ラクタム誘導体

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2419119A (en) *	1943-07-02	1947-04-15	Westinghouse Electric Corp	Apparatus for treating and storing meat
US2545491A (en) *	1945-10-25	1951-03-20	American Instr Co Inc	Apparatus for precision control of climatic conditions
US2825680A (en) *	1953-03-31	1958-03-04	Niagara Blower Co	Apparatus for concentrating aqueous solutions of hygroscopic organic substances
US3424231A (en) *	1967-03-23	1969-01-28	Andrew Truhan	Environmental chamber
US3415313A (en) *	1967-06-12	1968-12-10	Niagara Blower Co	Apparatus for producing air at widely different temperatures and relative humidities
US3671273A (en) *	1968-05-20	1972-06-20	Alec C Gunter	Apparatus for preparing a cocoa concentrate
US3617699A (en) *	1969-03-10	1971-11-02	Donald F Othmer	A system for electrically heating a fluid being transported in a pipe
US4103508A (en) *	1977-02-04	1978-08-01	Apple Hugh C	Method and apparatus for conditioning air
FR2578842B1 (fr)	1985-03-15	1987-04-10	Rhone Poulenc Sante	Nouveaux derives de la pyrrolo(1,2-a) azepinone, leur preparation et les compositions pharmaceutiques qui les contiennent
JPS62161786A (ja) *	1986-01-08	1987-07-17	Mitsubishi Chem Ind Ltd	ピロ−ル化合物
US4769998A (en) *	1986-04-25	1988-09-13	Advantage Electronics, Incorporated	Precision-controlled water chiller
JP3198117B2 (ja) *	1990-02-07	2001-08-13	サントリー株式会社	ピロロアゼピン誘導体
JPH0525128A (ja) *	1990-05-11	1993-02-02	Suntory Ltd	ピロロアゼピン誘導体の製造方法
US5397780A (en) *	1991-08-07	1995-03-14	Suntory Limited	Pyrroloazepine derivative
ATE236163T1 (de) *	1991-08-07	2003-04-15	Suntory Ltd	Pyrroloazepinverbindungen
US5544275A (en) *	1993-03-17	1996-08-06	Applied Materials, Inc.	Electrically heated fluid carrying conduit having integrated heating elements and electrical conductors
JP3714685B2 (ja) *	1994-05-18	2005-11-09	第一サントリーファーマ株式会社	ハイメニアルディシン及びその誘導体並びにそれらの合成中間体の製造法並びにその合成中間体
ATE251135T1 (de) *	1995-11-02	2003-10-15	Daiichi Suntory Pharma Co Ltd	Verfahren zur herstellung von 1-substituierten pyrrol-3-carbonsäure-derivaten
EP0807632B1 (en)	1995-12-01	2002-04-17	Suntory Limited	Pyrroloazepine derivatives
JPH10251258A (ja)	1997-03-14	1998-09-22	Suntory Ltd	ピロロアゼピン系化合物
JPH11193289A (ja)	1997-12-26	1999-07-21	Suntory Ltd	ピロールスルホンアミド誘導体

1996
- 1996-12-02 EP EP96939340A patent/EP0807632B1/en not_active Expired - Lifetime
- 1996-12-02 AT AT96939340T patent/ATE216388T1/de active
- 1996-12-02 JP JP52115297A patent/JP3563076B2/ja not_active Expired - Fee Related
- 1996-12-02 KR KR1019970705185A patent/KR19980701788A/ko not_active Abandoned
- 1996-12-02 ES ES96939340T patent/ES2179218T3/es not_active Expired - Lifetime
- 1996-12-02 CA CA002212092A patent/CA2212092A1/en not_active Abandoned
- 1996-12-02 HU HU9900672A patent/HUP9900672A3/hu unknown
- 1996-12-02 IL IL12143296A patent/IL121432A/xx not_active IP Right Cessation
- 1996-12-02 AU AU76558/96A patent/AU719230B2/en not_active Ceased
- 1996-12-02 DE DE69620745T patent/DE69620745T2/de not_active Expired - Fee Related
- 1996-12-02 US US08/875,495 patent/US5962448A/en not_active Expired - Fee Related
- 1996-12-02 WO PCT/JP1996/003522 patent/WO1997020845A1/ja active IP Right Grant
1999
- 1999-05-17 US US09/312,713 patent/US6258805B1/en not_active Expired - Fee Related
2001
- 2001-03-09 US US09/801,816 patent/US6489473B2/en not_active Expired - Fee Related
2002
- 2002-07-03 US US10/188,234 patent/US6713634B2/en not_active Expired - Fee Related

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH01151578A (ja) *	1987-09-03	1989-06-14	Glaxo Group Ltd	ラクタム誘導体
JPH02160786A (ja) *	1988-08-02	1990-06-20	Glaxo Group Ltd	ラクタム誘導体

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000048602A1 (en) *	1999-02-17	2000-08-24	Suntory Limited	Intermittent claudication therapeutic drugs comprising pyrroloazepines

Also Published As

Publication number	Publication date
DE69620745T2 (de)	2002-10-31
KR19980701788A (ko)	1998-06-25
IL121432A (en)	2000-09-28
US6258805B1 (en)	2001-07-10
HUP9900672A3 (en)	2001-11-28
EP0807632B1 (en)	2002-04-17
EP0807632A1 (en)	1997-11-19
ATE216388T1 (de)	2002-05-15
JP3563076B2 (ja)	2004-09-08
ES2179218T3 (es)	2003-01-16
US20030166926A1 (en)	2003-09-04
US6489473B2 (en)	2002-12-03
US5962448A (en)	1999-10-05
AU719230B2 (en)	2000-05-04
AU7655896A (en)	1997-06-27
CA2212092A1 (en)	1997-06-12
IL121432A0 (en)	1998-01-04
US20020072515A1 (en)	2002-06-13
EP0807632A4 (en)	1998-12-09
HUP9900672A2 (hu)	1999-06-28
DE69620745D1 (de)	2002-05-23
US6713634B2 (en)	2004-03-30

Legal Events

Date	Code	Title	Description
1997-06-12	AK	Designated states	Kind code of ref document: A1 Designated state(s): AU CA HU IL JP KR US
1997-06-12	AL	Designated countries for regional patents	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE
1997-07-30	WWE	Wipo information: entry into national phase	Ref document number: 1019970705185 Country of ref document: KR
1997-07-31	ENP	Entry into the national phase	Ref document number: 2212092 Country of ref document: CA Ref country code: CA Ref document number: 2212092 Kind code of ref document: A Format of ref document f/p: F
1997-07-31	WWE	Wipo information: entry into national phase	Ref document number: 1996939340 Country of ref document: EP
1997-08-21	WWE	Wipo information: entry into national phase	Ref document number: 08875495 Country of ref document: US
1997-09-10	121	Ep: the epo has been informed by wipo that ep was designated in this application
1997-11-19	WWP	Wipo information: published in national office	Ref document number: 1996939340 Country of ref document: EP
1998-06-25	WWP	Wipo information: published in national office	Ref document number: 1019970705185 Country of ref document: KR
2002-04-17	WWG	Wipo information: grant in national office	Ref document number: 1996939340 Country of ref document: EP
2005-07-15	WWG	Wipo information: grant in national office	Ref document number: 1019970705185 Country of ref document: KR

Publication	Publication Date	Title
WO1997020845A1 (en)	1997-06-12	Pyrroloazepine derivatives
AU8345491A (en)	1992-04-02	Heterocyclic derivatives
NO177535C (no)	1995-10-04	Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidforbindelser
AU4321397A (en)	1998-04-24	Pyrazolopyridylpyridazinone derivatives and process for preparing the same
IL97565A0 (en)	1992-06-21	Process for the preparation of chlorothiazole derivatives
DK0658548T3 (da)	1998-03-16	Benzensylfonamidderivat og fremgangsmåde til fremstilling deraf
HU902839D0 (en)	1991-03-28	Process for producing acriloyl-substituted pyrrole derivatives and pharmaceutical preparatives containing them
DK0595111T3 (da)	1998-04-14	Carbazolonderivater og fremgangsmåde til deres fremstilling
EP1070711A3 (en)	2001-01-31	Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
KR890011829A (ko)	1989-08-22	디우레아 유도체 및 이의 제조방법
SE8305918L (sv)	1983-10-27	Mellanprodukter for framstellning av bensimidazolderivat
WO1999033840A3 (en)	1999-09-10	Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha1-blocking action
CA2128202A1 (en)	1993-07-22	Alkyl Derivatives of Trazodone with CNS Activity
AU7529287A (en)	1988-01-14	Pristinamycin process
CA2093631A1 (en)	1993-02-08	Pyrroloazepine derivative
CA2168514A1 (en)	1996-09-11	Isocarbacyclin derivatives
WO1999033841A3 (en)	1999-09-02	Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action
KR960031429A (ko)	1996-09-17	치환된 벤젠설포닐우레아 및 벤젠설포닐티오우레아, 이들의 제조방법, 약제학적 제제의 제조를 위한 이들의 용도 및 이들을 함유하는 약제
AU640767B2 (en)	1993-09-02	15-deoxyprostaglandin derivative
DE3883434D1 (de)	1993-09-30	Mitomycinanaloge, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen.
DE69024154D1 (de)	1996-01-25	Pyrimidoindolderivate und Verfahren zu ihrer Herstellung
ATE139767T1 (de)	1996-07-15	Verfahren zur herstellung 5-pyrazolomerkaptan- derivate und dessen zwischenprodukte
AU1317688A (en)	1988-09-22	Benzoxazine derivatives and processes for preparation thereof
KR940002252A (ko)	1994-02-17	우수한 항균작용을 갖는 신규한 피리돈 카르복실산 유도체 및 그의 제조방법

WO1997020845A1 - Pyrroloazepine derivatives - Google Patents

Info

Links

Classifications

Landscapes

Priority Applications (9)

Applications Claiming Priority (4)

Related Child Applications (4)

Publications (1)

Family

ID=26387089

Family Applications (1)

Country Status (12)

Cited By (1)

Families Citing this family (12)

Citations (2)

Family Cites Families (21)

Patent Citations (2)

Cited By (1)

Also Published As

Similar Documents

Legal Events